Filing Details
- Accession Number:
- 0001127602-24-028580
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-04 09:59:45
- Reporting Period:
- 2024-12-02
- Accepted Time:
- 2024-12-04 09:59:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920148 | Labcorp Holdings Inc. | LH | Services-Medical Laboratories (8071) | 992588107 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1222831 | A Glenn Eisenberg | 531 South Spring Street Burlington NC 27215 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-12-02 | 8,923 | $209.25 | 40,212 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-12-02 | 2,788 | $221.67 | 43,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-12-02 | 11,711 | $240.43 | 31,289 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Options | Disposition | 2024-12-02 | 8,923 | $0.00 | 8,923 | $209.25 |
| Common Stock | Non-qualified Stock Options | Disposition | 2024-12-02 | 2,788 | $0.00 | 2,788 | $221.67 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-02-02 | 2031-02-01 | No | 4 | M | Direct |
| 5,577 | 2024-02-07 | 2033-02-06 | No | 4 | M | Direct |
Footnotes
- The price of $240.4279 per share represents a weighted average of sales prices ranging from $240.015 to $240.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a securityholder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.
- Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("LHI"), calculated pursuant to the terms of the Employee Matters Agreement by and between LHI and Fortrea.
- The option vested in three equal annual installments beginning on the date reflected in this column.
- The option vests in three equal annual installments beginning on the date reflected in this column.
Billionaire Hedge Funds
